請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71822完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 杜裕康 | |
| dc.contributor.author | Tzu-Ting Chen | en |
| dc.contributor.author | 陳姿婷 | zh_TW |
| dc.date.accessioned | 2021-06-17T06:11:02Z | - |
| dc.date.available | 2019-03-05 | |
| dc.date.copyright | 2019-03-05 | |
| dc.date.issued | 2018 | |
| dc.date.submitted | 2018-11-06 | |
| dc.identifier.citation | 1. Hill EE, Herijgers P, Herregods MC and Peetermans WE. Evolving trends in infective endocarditis. Clinical Microbiology and Infection. 2006;12:5-12.
2. Hoen B and Duval X. Infective Endocarditis. The New England Journal of Medicine. 2013;368:1425-1433. 3. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D and Durack DT. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007;116:1736-54. 4. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, Ishizuka N, Nakamura K, Taniguchi Y, Yoshioka K, Kawazoe K, Akaishi M, Niwa K, Nakazawa M, Kitamura S and Miyatake K. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circulation Journal. 2003;67:901-5. 5. Tomas Carmona I, Limeres Posse J, Diz Dios P and Mella Perez C. Bacterial endocarditis of oral etiology in an elderly population. Archives of Gerontology and Geriatrics. 2003;36:49-55. 6. Whatling PJ, Robb JD, Byrne J and Wendler O. Can we really do without antibiotic prophylaxis for infective endocarditis? BMJ Case Reports. 2011;2011. 7. Duval X, Millot S, Chirouze C, Selton-Suty C, Moby V, Tattevin P, Strady C, Euvrard E, Agrinier N, Thomas D, Hoen B and Alla F. Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study. Clinical Infectious Diseases. 2017;64:1678-1685. 8. Chen PC, Tung YC, Wu PW, Wu LS, Lin YS, Chang CJ, Kung S and Chu PH. Dental Procedures and the Risk of Infective Endocarditis. Medicine (Baltimore). 2015;94:e1826. 9. Porat Ben-Amy D, Littner M and Siegman-Igra Y. Are dental procedures an important risk factor for infective endocarditis? A case-crossover study. European Journal of Clinical Microbiology & Infectious Diseases. 2009;28:269-73. 10. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, Levison ME, Korzeniowski OM and Kaye D. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Annals of Internal Medicine. 1998;129:761-9. 11. Lacassin F, Hoen B, Leport C, Selton-Suty C, Delahaye F, Goulet V, Etienne J and Briancon S. Procedures associated with infective endocarditis in adults. A case control study. European Heart Journal. 1995;16:1968-74. 12. Guntheroth WG. How important are dental procedures as a cause of infective endocarditis? The American Journal of Cardiology. 1984;54:797-801. 13. van der Meer JT, Thompson J, Valkenburg HA and Michel MF. Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis. Archives of Internal Medicine. 1992;152:1869-73. 14. van der Meer JTM, Michel MF, Valkenburg HA, van der Meer JTM, van Wijk W, Thompson J and Vandenbroucke JP. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. The Lancet. 1992;339:135-139. 15. Taubert KA and Wilson W. Is endocarditis prophylaxis for dental procedures necessary? Heart Asia. 2017;9:63-67. 16. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J and Walker DM. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal. 2015;36:3075-128. 17. Danchin N, Duval X and Leport C. Prophylaxis of infective endocarditis: French recommendations 2002. Heart. 2005;91:715-8. 18. (NICE) Prophylaxis against infective endocarditis. National Institute for Health and Clinical Excellence, 2008. (with 2016 update). . 19. Simmons NA, Ball AP, Cawson RA, Eykyn SJ, Littler WA, McGowan DA, Oakley CM and Shanson DC. Antibiotic prophylaxis and infective endocarditis. Lancet. 1992;339:1292-3. 20. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P and Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. The New England Journal of Medicine. 2004;351:2611-8. 21. Scannapieco FA, Bush RB and Paju S. Associations Between Periodontal Disease and Risk for Atherosclerosis, Cardiovascular Disease, and Stroke. A Systematic Review. Annals of Periodontology. 2003;8:38-53. 22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine. 2005;352:1685-95. 23. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV and Sacco RL. Primary Prevention of Ischemic Stroke. The American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633. 24. Dietrich T, Webb I, Stenhouse L, Pattni A, Ready D, Wanyonyi KL, White S and Gallagher JE. Evidence summary: the relationship between oral and cardiovascular disease. British Dental Journal. 2017;222:381-385. 25. Schillinger T, Kluger W, Exner M, Mlekusch W, Sabeti S, Amighi J, Wagner O, Minar E and Schillinger M. Dental and periodontal status and risk for progression of carotid atherosclerosis: the inflammation and carotid artery risk for atherosclerosis study dental substudy. Stroke. 2006;37:2271-6. 26. Beck JD and Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. Journal of Periodontology. 2005;76:2089-100. 27. Minassian C, D'Aiuto F, Hingorani AD and Smeeth L. Invasive dental treatment and risk for vascular events: a self-controlled case series. Annals of Internal Medicine. 2010;153:499-506. 28. Haheim LL, Olsen I and Ronningen KS. Association between tooth extraction due to infection and myocardial infarction. Community Dentistry and Oral Epidemiology. 2011;39:393-7. 29. Nordendahl E, Kjellstrom B, Fored CM, Ekbom A, Svensson T, Norhammar A and Gustafsson A. Invasive Dental Treatment and Risk for a First Myocardial Infarction. Journal of Dental Research. 2018:22034518767834. 30. Matthews JD. INvasive dental treatment and risk for vascular events. Annals of Internal Medicine. 2011;154:441-441. 31. Weitz H and Merli G. Invasive dental treatment and risk for vascular events: Have we bitten off more than we can chew? Annals of Internal Medicine. 2010;153:542-543. 32. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P and Deanfield J. Treatment of periodontitis and endothelial function. The New England Journal of Medicine. 2007;356:911-20. 33. Ciruzzi M, Schargrodsky H, Pramparo P, Rivas Estany E, Rodriguez Naude L, de la Noval Garcia R, Gaxiola Cazarez S, Meaney E, Nass A, Finizola B and Castillo L. Attributable risks for acute myocardial infarction in four countries of Latin America. Medicina. 2003;63:697-703. 34. Piegas LS, Avezum A, Pereira JC, Neto JM, Hoepfner C, Farran JA, Ramos RF, Timerman A and Esteves JP. Risk factors for myocardial infarction in Brazil. American Heart Journal. 2003;146:331-8. 35. Boehme AK, Esenwa C and Elkind MSV. Stroke Risk Factors, Genetics, and Prevention. Circulation Research. 2017;120:472-495. 36. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. American Journal of Epidemiology. 1991;133:144-53. 37. Maclure M and Mittleman MA. Should we use a case-crossover design? Annual Review of Public Health. 2000;21:193-221. 38. Mittleman MA, Maclure M and Robins JM. Control sampling strategies for case-crossover studies: an assessment of relative efficiency. American Journal of Epidemiology. 1995;142:91-8. 39. Rothman KJ. Induction and latent periods. American Journal of Epidemiology. 1981;114:253-9. 40. Suissa S. The case-time-control design. Epidemiology. 1995;6:248-53. 41. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology. 1996;7:231-9. 42. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995;51:228-35. 43. Whitaker HJ, Farrington CP, Spiessens B and Musonda P. Tutorial in biostatistics: the self-controlled case series method. Statistics in Medicine. 2006;25:1768-97. 44. Whitaker HJ, Hocine MN and Farrington CP. The methodology of self-controlled case series studies. Statistical Methods in Medical Research. 2009;18:7-26. 45. National Health Insurance Administration, Ministry of Health and Welfare, Taiwan, R.O.C. (2014). National Health Insurance Annual Report 2014-2015. 46. Lipsitch M, Tchetgen ET and Cohen T. Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies. Epidemiology. 2010;21:383-388. 47. Farrington CP, Whitaker HJ and Hocine MN. Case Series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics. 2009;10:3-16. 48. Petersen I, Douglas I and Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354. 49. Tubiana S, Blotière P-O, Hoen B, Lesclous P, Millot S, Rudant J, Weill A, Coste J, Alla F and Duval X. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017;358. 50. Duval X, Alla F, Hoen B, Danielou F, Larrieu S, Delahaye F, Leport C and Briancon S. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clinical Infectious Diseases. 2006;42:e102-7. 51. Laupacis A, Sackett DL and Roberts RS. An assessment of clinically useful measures of the consequences of treatment. The New England Journal of Medicine. 1988;318:1728-33. 52. D'Aiuto F, Nibali L, Mohamed-Ali V, Vallance P and Tonetti MS. Periodontal therapy: a novel non-drug-induced experimental model to study human inflammation. Journal of Periodontal Research. 2004;39:294-9. 53. Beukers NG, van der Heijden GJ, van Wijk AJ and Loos BG. Periodontitis is an independent risk indicator for atherosclerotic cardiovascular diseases among 60 174 participants in a large dental school in the Netherlands. Journal of Epidemiology and Community Health. 2017;71:37-42. 54. Shiheido Y, Maejima Y, Suzuki JI, Aoyama N, Kaneko M, Watanabe R, Sakamaki Y, Wakayama K, Ikeda Y, Akazawa H, Ichinose S, Komuro I, Izumi Y and Isobe M. Porphyromonas gingivalis, a periodontal pathogen, enhances myocardial vulnerability, thereby promoting post-infarct cardiac rupture. Journal of Molecular and Cellular Cardiology. 2016;99:123-137. 55. Joshipura K. The relationship between oral conditions and ischemic stroke and peripheral vascular disease. The Journal of the American Dental Association. 2002;133 Suppl:23S-30S. 56. Buhlin K, Gustafsson A, Hakansson J and Klinge B. Oral health and cardiovascular disease in Sweden. Journal of Clinical Periodontology. 2002;29:254-9. 57. Ghizoni JS, Taveira LA, Garlet GP, Ghizoni MF, Pereira JR, Dionisio TJ, Brozoski DT, Santos CF and Sant'Ana AC. Increased levels of Porphyromonas gingivalis are associated with ischemic and hemorrhagic cerebrovascular disease in humans: an in vivo study. Journal of Applied Oral Science. 2012;20:104-12. 58. Cope AL and Chestnutt IG. Inappropriate prescribing of antibiotics in primary dental care: reasons and resolutions. Primary Dental Journal. 2014;3:33-7. 59. Brotons C, Benamouzig R, Filipiak KJ, Limmroth V and Borghi C. A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach? American Journal of Cardiovascular Drugs. 2015;15:113-33. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/71822 | - |
| dc.description.abstract | 背景:
侵入性牙齒治療可能會引起短暫的菌血症,因此被認為是心內膜炎、心肌梗塞、以及缺血性腦中風潛在的危險因子,可能的致病機轉為細菌透過侵入性牙齒治療所造成的傷口進入血液裡,細菌可能附著在功能不正常的心臟瓣膜或受損的心臟組織、抑或是進入到循環系統內,因此誘發心內膜炎,若細菌跑到血液中並附著在血管上,即可能引起系統性發炎症,進一步造成動脈硬化,誘發急性血管功能障礙,然而在過去的研究中,侵入性牙齒治療與心內膜炎、心肌梗塞、以及缺血性腦中風之間的關係還沒有一個定論,所以本研究的目的為探討侵入性牙齒治療與心內膜炎、心肌梗塞、以及缺血性腦中風的相關性。 方法: 本研究使用臺灣全民健康保險資料庫,我們應用兩種唯病例法研究設計來驗證假說,其中包含病例交叉(case-crossover)研究設計以及病例自我對照(self-controlled case series)研究設計,唯病例法研究設計的優點為不隨時間改變的干擾因子會自我校正,因此我們估計的相對風險可以避免干擾因子造成偏差。在病例交叉研究設計,我們使用條件式邏輯思迴歸模型來估計侵入性牙齒治療後發生心內膜炎、心肌梗塞、以及缺血性腦中風的風險,根據不同的併發症我們估計的暴露區間有所不同,針對心內膜炎,我們估計的暴露區間長度分別為ㄧ週、兩週、三週、和四週,而心肌梗塞以及缺血性腦中風的部分,我們估計的暴露區間長度分別為三天、七天、兩週、四週、八週、十二週、十六週、二十週、以及二十四週。在病例自我對照研究設計,我們使用條件式卜瓦松迴歸模型來估計侵入性牙齒治療後發生心內膜炎、心肌梗塞、以及缺血性腦中風的風險,我們分別估計侵入性牙齒治療後一至四週、五至八週、九至十二週、以及十三至十六週發生心內膜炎的風險,以及侵入性牙齒治療後一至三天、四至七天、八至十四天、三至四週、五至八週、九至十二週、十三至十六週、十七至二十週、和二十ㄧ至二十四週發生心肌梗塞與缺血性腦中風的風險。 結果: 在病例交叉研究設計中,我們總共納入9120位心內膜炎的個案、123819位心肌梗塞的個案、以及327179位缺血性腦中風的個案,而在病例自我對照研究設計中,我們總共納入 8181 位心內膜炎的個案、117655位心肌梗塞的個案、以及298757位缺血性腦中風的個案。心內膜炎風險估計的部分,在病例交叉研究設計中,當暴露區間長度為四週,其接受侵入性牙齒治療相對於沒有接受侵入性牙齒治療發生心內膜炎的勝算比為1.12 (95% 信賴區間:0.94-1.34),而在病例自我對照研究設計中,侵入性牙齒治療後四週相較於對照區間,其年齡校正的發生率比為1.14 (95% 信賴區間:1.02-1.26);心肌梗塞的部分,不論是病例交叉研究設計或是病例自我對照研究設計,我們有一致的結果:侵入性牙齒治療後24週相對於沒有接受侵入性牙齒治療,發生心肌梗塞的相對風險非常接近於1,或是風險未達統計上顯著差異;缺血性腦中風的部分,兩種研究設計估計的相對風險有一致的結果,侵入性牙齒治療後24週相對於沒有接受侵入性牙齒治療,發生缺血性腦中風的相對風險非常接近於1。 結論: 不論是病例交叉研究設計或是病例自我對照研究設計,我們的研究結果發現,侵入性牙齒治療後短期內不會增加心內膜炎、心肌梗塞、以及缺血性腦中風的風險,除此之外,針對高危險族群的部分,像是風濕性心臟病或是換過瓣膜的個案,研究結果顯示侵入性牙齒治療與心內膜炎無相關性,以及在年齡較大的個案中,侵入性牙齒治療與心肌梗塞及缺血性腦中風無相關性,因此,在臺灣族群使用預防性抗生素來降低心內膜炎的風險是不必要的,但是針對長期風險的部分,我們仍無法排除侵入性牙齒治療後會增加心肌梗塞以及缺血性腦中風風險之可能性。 | zh_TW |
| dc.description.abstract | BACKGROUND:
Invasive dental treatments (IDTs) can yield temporary bacteremia and has therefore been considered a potential risk factor of infective endocarditis (IE), myocardial infarction (MI) and ischemic stroke (IS). It is hypothesized that, through the trauma caused by IDTs, bacteria gain entry to the bloodstream and may attach to abnormal heart valves, attach to damaged heart tissue, or travel through the circulation, giving rise to IE. Bacterial dissemination from the oral cavity and systemic inflammation linked to IDT may induce a state of acute vascular dysfunction. However, the association between IDTs and IE, MI. and IS remains controversial. The aim of this study is to estimate the association between IDTs and IE, MI, and IS. METHODS: The data in this study were obtained from the Health Insurance Database in Taiwan. We selected two case-only study designs, case-crossover and self-controlled case series, to analyze the data. The advantage of these methods is that confounding factors which do not vary with time are adjusted for implicitly. In the case-crossover design, conditional logistic regression model with exposure to IDTs was used to estimate the risks of IE following an IDT with 4, 8, 12, and 16 weeks delay and the risk of MI/IS following an IDT with 3 days, 7 days, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, and 24 weeks delay, respectively. In the self-controlled case series design, conditional Poisson regression model was used to estimate the risk of IE for the risk periods of 1-4, 5-8, 9-12, and 13-16 weeks following an IDT and the risk of MI/IS for the risk periods of 1-3 days, 4-7 days, 8-14 days, 3-4 weeks, 5-8weeks, 9-12 weeks, 13-16 weeks, 17-20 weeks, and 21-24weeks following an IDT. RESULTS: In total, 9120 IE patients, 123,819 MI patients and 327,179 IS patients in the case-crossover design, and 8181 IE patients, 117,655 MI patients and 298,757 IS patients were included in the self-controlled case-series. The odds ratio of IE was 1.12 (95% Confidence Interval (CI): 0.94-1.34) for 4 weeks in the case-crossover design, and the age-adjusted incidence rate ratio of IE was 1.14 (95% CI: 1.02-1.26) for 1-4 weeks after IDTs in self-controlled case series design. Results from both study designs showed that the risk of MI within the first 24 weeks was no significantly different or very close to unity. For IS, we observed no association between IDTs and IS or the risk is very close to unity. We also did not find any association between high risk IDTs and a larger risk of IE, MI and IS. CONCLUSIONS: In both study designs, we did not observe a clinically larger risk for IE, MI and IS in the short periods after IDTs. We also found no association between IDTs and IE among high-risk patients, such as those with rheumatic heart disease or valve replacement, and no association between IDTs and MI and IS among older patients. Therefore, antibiotic prophylaxis for prevention of IE is not required for the Taiwanese population. However, we cannot exclude that dental infections and diseases may yield a long-term effect on MI and IS. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-17T06:11:02Z (GMT). No. of bitstreams: 1 ntu-107-D02849003-1.pdf: 4385743 bytes, checksum: eabb85fc7ca9d584581cdf8b637a1bd1 (MD5) Previous issue date: 2018 | en |
| dc.description.tableofcontents | 論文口試委員審定書 i
Acknowledgement ii 摘要 iii Abstract vi Contents ix Contents of Tables xii Contents of Figures xiii Chapter 1 Introduction 1 Chapter 2 Literature review 3 2.1 Invasive dental treatments and infective endocarditis 3 2.2 Invasive dental treatments and vascular events 5 2.3 Case-only design 7 2.3.1 Case-crossover Design 7 2.3.2 Self-controlled Case Series 9 Chapter 3 Objective 12 Chapter 4 Material and method 14 4.1 Health Insurance Database 14 4.2 Study population 14 4.3 Exposure: invasive dental treatments 15 4.4 Study design 17 4.4.1 Case-crossover Design 18 4.4.2 Self-controlled Case Series Design 21 4.5 Comorbidities 28 Chapter 5 Results 31 5.1 Infective endocarditis 31 5.1.1 Case-crossover design 31 5.1.2 Self-controlled case series design 36 5.2 Myocardial infarction and ischemic stroke 49 5.2.1 Case-crossover design 49 5.2.2 Self-controlled case series design 59 5.3 Burn injury 69 5.3.1 Case-crossover design 69 5.3.2 Self-controlled case series design 78 Chapter 6 Discussion 87 6.1 Main findings 87 6.2 Comparison with previous studies 88 6.3 Strength and weakness 92 Chapter 7 Conclusion and future work 98 References 102 Appendix 113 | |
| dc.language.iso | en | |
| dc.subject | 心內膜炎 | zh_TW |
| dc.subject | 缺血性腦中風 | zh_TW |
| dc.subject | 病例交叉研究設計 | zh_TW |
| dc.subject | 心肌梗塞 | zh_TW |
| dc.subject | 病例自我對照研究設計 | zh_TW |
| dc.subject | 侵入性牙齒治療 | zh_TW |
| dc.subject | invasive dental treatments | en |
| dc.subject | self-controlled case series design | en |
| dc.subject | infective endocarditis | en |
| dc.subject | myocardial infarction | en |
| dc.subject | case-crossover design | en |
| dc.subject | ischemic stroke | en |
| dc.title | 臺灣侵入性牙齒治療後發生心肌梗塞、缺血性腦中風、以及心內膜炎之風險:唯病例法研究 | zh_TW |
| dc.title | Risk of myocardial infarction, ischemic stroke, and endocarditis after invasive dental treatments in Taiwan: a case-only study | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 107-1 | |
| dc.description.degree | 博士 | |
| dc.contributor.oralexamcommittee | 李文宗,季麟揚,賴超倫,蕭斐元 | |
| dc.subject.keyword | 病例交叉研究設計,病例自我對照研究設計,侵入性牙齒治療,心內膜炎,心肌梗塞,缺血性腦中風, | zh_TW |
| dc.subject.keyword | case-crossover design,self-controlled case series design,infective endocarditis,myocardial infarction,ischemic stroke,invasive dental treatments, | en |
| dc.relation.page | 113 | |
| dc.identifier.doi | 10.6342/NTU201804262 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2018-11-06 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-107-1.pdf 未授權公開取用 | 4.28 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
